Learning Objectives:

  1. To understand the role of biomarkers for new therapy development in Parkinson’s disease
  2. To appreciate the insights that biomarkers provide for understanding the pathogenesis of PD
  3. To understand the use of biomarkers in clinical practice of PD
Session date: 
04/14/2022 - 7:30am to 8:30am CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Un Jung Kang